Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy
Authors
Keywords
-
Journal
Stem Cells International
Volume 2017, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2017-05-19
DOI
10.1155/2017/8765154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
- (2017) Niclas E. Bengtsson et al. Nature Communications
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders
- (2016) Daria Wojtal et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells
- (2016) Courtney S. Young et al. Cell Stem Cell
- Generation of Induced Pluripotent Stem Cells From Patients With Duchenne Muscular Dystrophy and Their Induction to Cardiomyocytes
- (2016) Akihito Hashimoto et al. International Heart Journal
- Paracrine and endocrine modes of myostatin action
- (2016) Yun-Sil Lee et al. JOURNAL OF APPLIED PHYSIOLOGY
- Prevention of Muscle Wasting by CRISPR/Cas9-mediated Disruption of Myostatin In Vivo
- (2016) Yuda Wei et al. MOLECULAR THERAPY
- In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
- (2016) Keiichiro Suzuki et al. NATURE
- New CRISPR–Cas systems from uncultivated microbes
- (2016) David Burstein et al. NATURE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Failure to detect DNA-guided genome editing using Natronobacterium gregoryi Argonaute
- (2016) Seung Hwan Lee et al. NATURE BIOTECHNOLOGY
- DNA-guided genome editing using the Natronobacterium gregoryi Argonaute
- (2016) Feng Gao et al. NATURE BIOTECHNOLOGY
- Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells
- (2016) Daesik Kim et al. NATURE BIOTECHNOLOGY
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Pluripotent stem cells in disease modelling and drug discovery
- (2016) Yishai Avior et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy
- (2016) David Gloss et al. NEUROLOGY
- Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations
- (2016) Ignazio Maggio et al. NUCLEIC ACIDS RESEARCH
- Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model
- (2016) In Young Choi et al. Cell Reports
- Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method
- (2016) Jean-Paul Iyombe-Engembe et al. Molecular Therapy-Nucleic Acids
- Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy
- (2016) Valeria Ricotti et al. PLoS One
- Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells
- (2016) Ignazio Maggio et al. Scientific Reports
- Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons
- (2016) Keiko Imamura et al. Scientific Reports
- From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing
- (2015) Akitsu Hotta et al. Annual Review of Genetics
- Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9
- (2015) Chul-Yong Park et al. Cell Stem Cell
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
- (2015) Catherine L. Bladen et al. HUMAN MUTATION
- Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases
- (2015) Kentaro Ishida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger Nucleases
- (2015) David G Ousterout et al. MOLECULAR THERAPY
- Engineered CRISPR-Cas9 nucleases with altered PAM specificities
- (2015) Benjamin P. Kleinstiver et al. NATURE
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy
- (2015) David G. Ousterout et al. Nature Communications
- Induced pluripotent stem cells as a model for diabetes investigation
- (2015) J. Stepniewski et al. Scientific Reports
- Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells
- (2015) Emi Shoji et al. Scientific Reports
- Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
- (2015) Hongmei Lisa Li et al. Stem Cell Reports
- Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 andpiggyBac
- (2014) Fei Xie et al. GENOME RESEARCH
- Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
- (2014) Carolin Anders et al. NATURE
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- A guide to genome engineering with programmable nucleases
- (2014) Hyongbum Kim et al. NATURE REVIEWS GENETICS
- Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation
- (2014) M. Jinek et al. SCIENCE
- Stem Cell Transplantation for Muscular Dystrophy: The Challenge of Immune Response
- (2014) Sara Martina Maffioletti et al. Biomed Research International
- Genetic and Chemical Correction of Cholesterol Accumulation and Impaired Autophagy in Hepatic and Neural Cells Derived from Niemann-Pick Type C Patient-Specific iPS Cells
- (2014) Dorothea Maetzel et al. Stem Cell Reports
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
- (2013) Luke A. Gilbert et al. CELL
- Genetic correction using engineered nucleases for gene therapy applications
- (2013) Hongmei Lisa Li et al. DEVELOPMENT GROWTH & DIFFERENTIATION
- Anti-Dystrophin T Cell Responses in Duchenne Muscular Dystrophy: Prevalence and a Glucocorticoid Treatment Effect
- (2013) Kevin M. Flanigan et al. HUMAN GENE THERAPY
- DNA targeting specificity of RNA-guided Cas9 nucleases
- (2013) Patrick D Hsu et al. NATURE BIOTECHNOLOGY
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- RNA-guided gene activation by CRISPR-Cas9–based transcription factors
- (2013) Pablo Perez-Pinera et al. NATURE METHODS
- CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
- (2013) Thomas J. Cradick et al. NUCLEIC ACIDS RESEARCH
- Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro
- (2013) Akihito Tanaka et al. PLoS One
- Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis
- (2013) Z. Hou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exon Skipping and Gene Transfer Restore Dystrophin Expression in Human Induced Pluripotent Stem Cells-Cardiomyocytes Harboring DMD Mutations
- (2013) Emily Dick et al. STEM CELLS AND DEVELOPMENT
- An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells
- (2013) Antonio Filareto et al. Nature Communications
- Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery
- (2012) Jiho Jang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy
- (2011) George Silva et al. CURRENT GENE THERAPY
- Endonucleases: tools to correct the dystrophin gene
- (2011) Joel Rousseau et al. JOURNAL OF GENE MEDICINE
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophies: Validation of an Exon-Skipping Approach to Restore Dystrophin in Duchenne Muscular Dystrophy Cells
- (2009) Soraya Chaouch et al. HUMAN GENE THERAPY
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
- (2009) Katharine Bushby et al. LANCET NEUROLOGY
- Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
- (2009) Yasuhiro Kazuki et al. MOLECULAR THERAPY
- Disease-Specific Induced Pluripotent Stem Cells
- (2008) In-Hyun Park et al. CELL
- Comparison of nonhomologous end joining and homologous recombination in human cells
- (2008) Z MAO et al. DNA REPAIR
- DNA-binding Specificity Is a Major Determinant of the Activity and Toxicity of Zinc-finger Nucleases
- (2007) Tatjana I Cornu et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started